All In Biotech

Drug Trial Radar · NCT01467466

Prevention of Serious Adverse Events Following Angiography

CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)

Last checked: Nov 20, 2026Latest source record: Nov 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 5,177 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

5,177

Actual

Start

Oct 7, 2013

Primary completion

Sep 29, 2017

Study completion Oct 17, 2017

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
Collaborators
The George Institute
First posted
Nov 8, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine (NAC) with oral placebo for the prevention of serious adverse outcomes following angiographic procedures in high-risk patients.

Conditions

  • Acute Renal Failure
  • Kidney Disease
  • Coronary Artery Disease

Interventions

  • IV isotonic salineDrug

    The investigators will administer 3 ml/kg of isotonic saline over 1 hour at an infusion rate of not less than 1 mL/kg per hour and not more than 3 mL/kg per hour prior to the angiographic procedure, 1-1.5ml/kg per hour during angiography, and 6 ml/kg of isotonic saline over 4 hours following the procedure at an infusion rate of not less than 1 mL/kg per hour and not more than 1.5 mL/kg per hour. Providers will retain discretion to administer larger volumes of isotonic saline (up to a maximum of 12 mL/kg) over durations of up to 12 hours pre and 12 hours post-procedure.

  • IV isotonic bicarbonateDrug

    The investigators will administer 3 ml/kg of isotonic bicarbonate over 1 hour at an infusion rate of not less than 1 mL/kg per hour and not more than 3 mL/kg per hour prior to the angiographic procedure, 1-1.5ml/kg per hour during angiography, and 6 ml/kg of isotonic bicarbonate over 4 hours following the procedure at an infusion rate of not less than 1 mL/kg per hour and not more than 1.5 mL/kg per hour. Providers will retain discretion to administer larger volumes of isotonic bicarbonate (up to a maximum of 12 mL/kg) over durations of up to 12 hours pre and 12 hours post-procedure.

  • N-acetylcysteineDrug

    NAC will be administered at a dose of 1200mg orally 1 hour prior to angiography, 1 hour following the procedure, and then twice daily for the next 4 days.

  • PlaceboDrug

    A placebo study drug capsule will be administered orally 1 hour prior to angiography, 1 hour following the procedure, and then twice daily for the next 4 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Serious, Adverse, Patient-Centered Events, Including Death, Need for Acute Dialysis, or Persistent Decline in Kidney Function, Comparing Intravenous Sodium Bicarbonate With Intravenous Sodium Chloride.Time frame: Within 90 days following angiography
  2. Number of Participants With Serious, Adverse, Patient-Centered Events, Including Death, Need for Acute Dialysis, or Persistent Decline in Kidney Function, Comparing Oral N-Acetylcysteine With Oral Placebo.Time frame: Within 90 days following angiography

Locations

54 sites in 4 countries. Site status is shown where the registry gives one.

  • Southern Arizona VA Health Care System, Tucson

    Tucson, Arizona

  • Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR

    Little Rock, Arkansas

  • VA Palo Alto Health Care System, Palo Alto, CA

    Palo Alto, California

  • San Francisco VA Medical Center, San Francisco, CA

    San Francisco, California

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    West Los Angeles, California

  • Bay Pines VA Healthcare System, Pay Pines, FL

    Bay Pines, Florida

  • North Florida/South Georgia Veterans Health System, Gainesville, FL

    Gainesville, Florida

  • Charlie Norwood VA Medical Center, Augusta, GA

    Augusta, Georgia

  • Atlanta VA Medical and Rehab Center, Decatur, GA

    Decatur, Georgia

  • Jesse Brown VA Medical Center, Chicago, IL

    Chicago, Illinois

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN

    Indianapolis, Indiana

  • VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA

    West Roxbury, Massachusetts

  • VA Ann Arbor Healthcare System, Ann Arbor, MI

    Ann Arbor, Michigan

  • Minneapolis VA Health Care System, Minneapolis, MN

    Minneapolis, Minnesota

  • Kansas City VA Medical Center, Kansas City, MO

    Kansas City, Missouri

  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO

    St Louis, Missouri

  • New Mexico VA Health Care System, Albuquerque, NM

    Albuquerque, New Mexico

  • VA Western New York Healthcare System, Buffalo, NY

    Buffalo, New York

  • Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY

    New York, New York

  • Durham VA Medical Center, Durham, NC

    Durham, North Carolina

  • Cincinnati VA Medical Center, Cincinnati, OH

    Cincinnati, Ohio

  • Louis Stokes VA Medical Center, Cleveland, OH

    Cleveland, Ohio

  • Dayton VA Medical Center, Dayton, OH

    Dayton, Ohio

  • Oklahoma City VA Medical Center, Oklahoma City, OK

    Oklahoma City, Oklahoma

  • Portland VA Medical Center, Portland, OR

    Portland, Oregon

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

    Pittsburgh, Pennsylvania

  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina

  • Memphis VA Medical Center, Memphis, TN

    Memphis, Tennessee

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

    Dallas, Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX

    Houston, Texas

  • South Texas Health Care System, San Antonio, TX

    San Antonio, Texas

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah

  • Hunter Holmes McGuire VA Medical Center, Richmond, VA

    Richmond, Virginia

  • Salem VA Medical Center, Salem, VA

    Salem, Virginia

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington

  • Canberra Hospital

    Canberra, Australian Capital Territory, Australia

  • Concord Hospital

    Concord, New South Wales, Australia

  • Gosford Hospital

    Gosford, New South Wales, Australia

  • Nepean Hospital

    Kingswood, New South Wales, Australia

  • St. George Hospital

    Kogarah, New South Wales, Australia

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.